PT  - JOURNAL ARTICLE
AU  - Furr, Noah
AU  - Ulmer, Ansley
AU  - Cardon, Brock
ED  - Mullen, Rebecca
TI  - Shoring Up Osteoporosis Management: A Fresh Start?
AID  - 10.3122/jabfm.2024.240060R0
DP  - 2024 May 01
TA  - The Journal of the American Board of Family
                Medicine
PG  - 490--493
VI  - 37
IP  - 3
4099  - http://www.jabfm.org/content/37/3/490.short
4100  - http://www.jabfm.org/content/37/3/490.full
SO  - J Am Board Fam Med2024 May 01; 37
AB  - Anabolic bone agents, such as parathyroid hormone receptor agonists (teriparatide and abaloparatide) and sclerostin-inhibiting monoclonal antibody (romosozumab), are superior at preventing clinically significant fractures and/or vertebral fractures in women with and without severe osteoporosis compared with bisphosphonates.